Literature DB >> 25647209

Evaluating elevated bilirubin levels in asymptomatic adults.

Lisa B VanWagner1, Richard M Green2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25647209      PMCID： PMC4424929          DOI： 10.1001/jama.2014.12835

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Gilbert syndrome.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Liapi; Themistocles Karpathios
Journal:  Eur J Pediatr       Date:  2011-12-09       Impact factor: 3.183

Review 2.  Pharmacogenetics of Gilbert's syndrome.

Authors:  Christian P Strassburg
Journal:  Pharmacogenomics       Date:  2008-06       Impact factor: 2.533

3.  Gilbert's syndrome.

Authors:  Lee C Claridge; Matthew J Armstrong; Caroline Booth; Paramjit S Gill
Journal:  BMJ       Date:  2011-04-19

4.  Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.

Authors:  S Stender; R Frikke-Schmidt; B G Nordestgaard; P Grande; A Tybjaerg-Hansen
Journal:  J Intern Med       Date:  2012-08-20       Impact factor: 8.989

5.  Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer.

Authors:  Heather Taffet Gold; Michael J Hall; Victoria Blinder; Bruce R Schackman
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

6.  Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection.

Authors:  Andrew C Bulmer; Joanne T Blanchfield; Istvan Toth; Robert G Fassett; Jeff S Coombes
Journal:  Atherosclerosis       Date:  2007-12-26       Impact factor: 5.162

7.  Gilbert's syndrome and the risk of death: a population-based cohort study.

Authors:  Laura J Horsfall; Irwin Nazareth; Stephen P Pereira; Irene Petersen
Journal:  J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 4.029

8.  Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease.

Authors:  Stefan Stender; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

9.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Authors:  P J Bosma; J R Chowdhury; C Bakker; S Gantla; A de Boer; B A Oostra; D Lindhout; G N Tytgat; P L Jansen; R P Oude Elferink
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245
  9 in total
  7 in total

1.  Analyses of biomarker traits in diverse UK biobank participants identify associations missed by European-centric analysis strategies.

Authors:  Yun Li; Laura M Raffield; Quan Sun; Misa Graff; Bryce Rowland; Jia Wen; Le Huang; Tyne W Miller-Fleming; Jeffrey Haessler; Michael H Preuss; Jin-Fang Chai; Moa P Lee; Christy L Avery; Ching-Yu Cheng; Nora Franceschini; Xueling Sim; Nancy J Cox; Charles Kooperberg; Kari E North
Journal:  J Hum Genet       Date:  2021-08-11       Impact factor: 3.755

2.  Thiamethoxam induced hepatotoxicity and pro-carcinogenicity in rabbits via motivation of oxidative stress, inflammation, and anti-apoptotic pathway.

Authors:  Osama S El Okle; Omnia I El Euony; Asmaa F Khafaga; Mohamed A Lebda
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-01       Impact factor: 4.223

Review 3.  Bilirubin in coronary artery disease: Cytotoxic or protective?

Authors:  Nancy Gupta; Tavankit Singh; Rahul Chaudhary; Sushil K Garg; Gurprataap Singh Sandhu; Varun Mittal; Rahul Gupta; Roxana Bodin; Sachin Sule
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

4.  Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis.

Authors:  Petra Adamkova; Petra Hradicka; Sona Gancarcikova; Monika Kassayova; Lubos Ambro; Izabela Bertkova; Martin Maronek; Silvia Farkasova Iannaccone; Vlasta Demeckova
Journal:  Pathogens       Date:  2021-02-02

5.  Hesperidin ameliorates cisplatin induced hepatotoxicity and attenuates oxidative damage, cell apoptosis, and inflammation in rats.

Authors:  Dina M Aboraya; Ayman El Baz; Engy F Risha; Fatma M Abdelhamid
Journal:  Saudi J Biol Sci       Date:  2022-01-29       Impact factor: 4.052

6.  Kinetin Ameliorates Cisplatin-Induced Hepatotoxicity and Lymphotoxicity via Attenuating Oxidative Damage, Cell Apoptosis and Inflammation in Rats.

Authors:  Moustafa Fathy; Mostafa A Darwish; Al-Shaimaa M Abdelhamid; Gehad M Alrashedy; Othman Ali Othman; Muhammad Naseem; Thomas Dandekar; Eman M Othman
Journal:  Biomedicines       Date:  2022-07-06

7.  N-Acetylcysteine Supplementation for the Prevention of Postoperative Liver Dysfunction after On-Pump Cardiac Surgery.

Authors:  Rajeev Kumar; Manjari Bansal; Soumya Sankar Nath; Virendra Kumar; Deepak Malviya; Dharmendra Srivastava
Journal:  Turk J Anaesthesiol Reanim       Date:  2021-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.